Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / COMMON STOCK
-
Total 13F shares
-
65,071,757
-
Share change
-
-1,220,986
-
Total reported value
-
$2,278,570,190
-
Put/Call ratio
-
17%
-
Price per share
-
$35.02
-
Number of holders
-
183
-
Value change
-
-$60,091,831
-
Number of buys
-
97
-
Number of sells
-
92
Institutional Holders of GLOBAL BLOOD THERAPEUTICS INC - COMMON STOCK (GBT) as of Q2 2021
As of 30 Jun 2021,
GLOBAL BLOOD THERAPEUTICS INC - COMMON STOCK (GBT) was held by
183 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
65,071,757 shares.
The largest 10 holders included
JANUS HENDERSON GROUP PLC, BANK OF AMERICA CORP /DE/, VANGUARD GROUP INC, BlackRock Inc., PERCEPTIVE ADVISORS LLC, PRICE T ROWE ASSOCIATES INC /MD/, BAKER BROS. ADVISORS LP, STATE STREET CORP, FRANKLIN RESOURCES INC, and Point72 Asset Management, L.P..
This page lists
183
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.